Back to today’s briefing

Story perspectives

Brexit's Hidden Toll: UK Cancer Patients Face Drug Crisis

4/21/2025

31 2

Summary

Story summary

A leaked report uncovers the troubling impact of Brexit on UK cancer patients, revealing that soaring drug import costs are obstructing access to groundbreaking treatments and clinical trials. Children are bearing the brunt, with some being denied crucial medications. Experts caution that these challenges threaten not only patient outcomes but also the future of global cancer research collaboration.

1 of 1

Story summary

A leaked report uncovers the troubling impact of Brexit on UK cancer patients, revealing that soaring drug import costs are obstructing access to groundbreaking treatments and clinical trials. Children are bearing the brunt, with some being denied crucial medications. Experts caution that these challenges threaten not only patient outcomes but also the future of global cancer research collaboration.